QQ客服 官方微博 反馈留言

	Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial
	Feng, Fei-Er; Feng, Ru; Wang, Min; Zhang, Jia-Min; Jiang, Hao; Jiang, Qian; Lu, Jin; Liu, Hui; Peng, Jun; Hou, Ming
刊名	LANCET HAEMATOLOGY
	2017
卷号	4期号:10页码:E487-E496
DOI	10.1016/S2352-3026(17)30170-9
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4586032
专题	山东大学
作者单位	Peking Univ,
推荐引用方式 GB/T 7714	Feng, Fei-Er,Feng, Ru,Wang, Min,et al. Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial[J]. LANCET HAEMATOLOGY,2017,4(10):E487-E496.
APA	Feng, Fei-Er.,Feng, Ru.,Wang, Min.,Zhang, Jia-Min.,Jiang, Hao.,...&Shen, Jian-Li 更多.(2017).Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial.LANCET HAEMATOLOGY,4(10),E487-E496.
MLA	Feng, Fei-Er,et al."Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial".LANCET HAEMATOLOGY 4.10(2017):E487-E496.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。